Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CRBN | Q96SW2 | 12/20 | 0.61 |
| ▸ | ESR1 | P03372 | 1/20 | 0.57 |
| ▸ | CSNK1A1 | P48729 | 2/20 | 0.55 |
| ▸ | IKZF1 | Q13422 | 1/20 | 0.52 |
| ▸ | IKZF2 | Q9UKS7 | 6/20 | 0.52 |
| ▸ | WIZ | O95785 | 1/20 | 0.51 |
| ▸ | GSPT1 | P15170 | 1/20 | 0.49 |
| ▸ | DDB1 | Q16531 | 1/20 | 0.49 |
| ▸ | IKZF3 | Q9UKT9 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24207552 | 1.00 | CRBN (0.61) | CRBNESR1CSNK1A1IKZF1IKZF2 | |
| SCHEMBL30906253 | 0.94 | CRBN (0.63) | CRBNESR1CSNK1A1IKZF1IKZF2 | |
| SCHEMBL30889713 | 0.93 | CRBN (0.57) | CRBNESR1CSNK1A1IKZF1IKZF2 | |
| SCHEMBL30906266 | 0.92 | CRBN (0.55) | CRBNESR1CSNK1A1IKZF1IKZF2 | |
| SCHEMBL30822468 | 0.92 | CRBN (0.61) | CRBNESR1CSNK1A1GSPT1IKZF3 | |
| SCHEMBL31586284 | 0.92 | CRBN (0.58) | CRBNESR1CSNK1A1IKZF1IKZF2 | |
| SCHEMBL31586767 | 0.90 | CRBN (0.56) | CRBNESR1CSNK1A1IKZF1IKZF2 | |
| SCHEMBL24734973 | 0.90 | CRBN (0.56) | CRBNESR1CSNK1A1IKZF1IKZF2 | |
| SCHEMBL24734976 | 0.89 | CRBN (0.55) | CRBNESR1CSNK1A1IKZF1IKZF2 | |
| SCHEMBL30822469 | 0.89 | CRBN (0.55) | CRBNESR1CSNK1A1IKZF1IKZF2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025103502-A1 | COMPOUNDS AND METHODS OF TREATING CANCERS | CULLGEN INC. (US) | 2025-05-22 | — | — | WO | disclosed |